2.12MMarket Cap
LossP/E TTM
Moleculin Biotech Inc's Company Valuation
Currency: USD Updated: 2026-07-31The current valuation score of Moleculin Biotech Inc is 7.38, ranking 178 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.02, which is -70.04% below the recent high of -0.01 and -14417.00% above the recent low of -3.59.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.